Preoperative Radiation Therapy with Concurrent Capecitabine, Bevacizumab and Erlotinib for Rectal Cancer: A Phase I Trial

This phase I trial evaluated preoperative radiotherapy with concurrent capecitabine, bevacizumab and erlotinib for rectal cancer. Eighteen patients were evaluable. Treatment was well tolerated, and the maximum tolerated dose (MTD) was not reached. One patient had grade 3 acute toxicity and 3 patient...

Full beskrivning

Sparad:
Bibliografiska uppgifter
I publikationen:Int J Radiat Oncol Biol Phys
Huvudupphovsmän: Das, Prajnan, Eng, Cathy, Rodriguez-Bigas, Miguel A., Chang, George J., Skibber, John M., You, Y. Nancy, Maru, Dipen M., Munsell, Mark F., Clemons, Marilyn V, Kopetz, Scott E., Garrett, Christopher R., Shureiqi, Imad, Delclos, Marc E., Krishnan, Sunil, Crane, Christopher H.
Materialtyp: Artigo
Språk:Inglês
Publicerad: 2013
Ämnen:
Article
Länkar:https://ncbi.nlm.nih.gov/pmc/articles/PMC5592790/
https://ncbi.nlm.nih.gov/pubmed/24315563
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.ijrobp.2013.10.034
Taggar: Lägg till en tagg
Inga taggar, Lägg till första taggen!

Liknande verk